TNFR1/p38αMAPK signaling in Nex+ supraspinal neurons regulates sex-specific chronic neuropathic pain
Kathryn A. SwansoniD, Kayla L. NguyeniD, Shruti GuptaiD, Jerome RicardiD, John R. BetheaiD
Abstract
Upregulation of soluble tumor necrosis factor (sTNF) cytokine signaling through TNF receptor 1 (TNFR1) and subsequent neuronal hyperexcitability are observed in both animal models and human chronic neuropathic pain (CNP) (Clark et al., 2013; Empl et al., 2001; Ji et al., 2018; Lindenlaub and Sommer, 2003). To test the hypothesis that supraspinal circuitry is critical to pain chronification, we studied the intersect between supraspinal TNFR1 mediated neuronal signaling and sex specificity by selectively removing TNFR1 in Nex+ neurons in adult mice (NexCreERT2::TNFR1f/f). We determined that following chronic constriction injury (CCI), pain resolves in males; however, female acute pain transitions to chronic. Subsequently, we investigated two downstream pathways, p38MAPK and NF-{kappa}B, important in TNFR1 signaling and injury response. We detected p38MAPK and NF-{kappa}B activation in male cortical tissue; however, p38MAPK phosphorylation was reduced in NexCreERT2::TNFR1f/f males. We observed similar behavioral results following CCI in NexCreERT2::p38MAPKf/f mice. Previously, we established estrogens ability to modulate sTNF/TNFR1 signaling in CNP, which may contribute to female prevalence of CNP (Bouhassira et al., 2008; Claiborne et al., 2006; de Mos et al., 2007; Del Rivero et al., 2019; Li et al., 2009). To explore the intersection between estrogen and inflammation in CNP we used a combination therapy of an estrogen receptor {beta} (ER {beta}) inhibitor with a sTNF/TNFR1 or general p38MAPK inhibitor. We determined both combination therapies lend "male-like" therapeutic relief to females following CCI. These data suggest that TNFR1/p38MAPK signaling in Nex+ neurons in CNP is male-specific and lack of therapeutic efficacy following sTNF inhibition in females is due to ER {beta} interference. These studies highlight sex-specific differences in pathways important to pain chronification and elucidate potential therapeutic strategies that would be effective in both sexes.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Hippocampal CA3 Nex/Neurod6+ neuron-specific TNFR2 alleviates chronic neuropathic pain by sex-dependently engaging opioid and endocannabinoid pathways
Sreejita Arnab, Payam A. Fathi, … John R. Bethea·bioRxiv·Nov 24, 2025
- Neuroendocrine mechanisms governing sex-differences in chronic pain involve prolactin receptor sensory neuron signaling
Candler A. Paige, Priscilla A. Barba-Escobedo, … Theodore John Price·Journal of NeurosciencePeer-reviewed·Aug 12, 2020
- GPR171 Agonist Reduces Chronic Neuropathic and Inflammatory Pain in Male, but not in Female Mice
A. Ram, T. Edwards, … E. Bobeck·bioRxiv·Apr 16, 2021
- Sex specific axon initial segment plasticity underlies cortical hyperexcitability in trigeminal pain
Justine Loudan, Karine Hérault, … Mickaël Zbili·bioRxiv·Oct 11, 2025
- Sex-dependent endocannabinoid adaptations in supraspinal pain modulatory circuits after peripheral nerve injury
Laura Boullon, David P. Finn, Alvaro Llorente‐Berzal·bioRxiv·Oct 16, 2026
- Sexual dimorphism in a neuronal mechanism of spinal hyperexcitability across rodent and human models of pathological pain
Annemarie Dedek, Jian Xu, … Michael E. Hildebrand·BrainPeer-reviewed·Oct 26, 2021